Ciloa SAS

Ciloa, Inspired by exosomes

Who is Ciloa SAS?

Ciloa is dedicated to the production of fully native membrane proteins on exosomes. Ciloa exosomes offer a disruptive way to develop a new generation of therapeutic and preventive vaccines, monoclonal antibodies, immunotherapies, and therapeutic vectors carrying drug cargo. Ciloa is dedicated to the development of new high-potential therapies through its bio-drug development technology using exosomes. Ciloa has already developed a pioneering technology for more than 15 years. Ciloa's management team is dedicated to science and innovation, and has the skills to lead high potential therapies development. Ciloa’s business model includs partnerships, at the scientific and academic level, as well as at the commercial level in the development of drug candidates. Ciloa is dedicated to the development of new high potential therapies. Ciloa’s technology allows to address oncology, infectiology, cardiology, genetic and neurological diseases, and more.

This company is:

Manufacturer

Montpellier, France

11-50 Employees

Founding year: 2011

Products & services of Ciloa SAS

Product

Verified

Ciloa @France Bioproduction 2021 - Ciloa

Ciloa is pleased to be a partner of the 5th edition of the France Bioproduction congress. Meet Robert Mamoun, Philippe Menasché and Guillaume Van Niel at the workshop “Exosomes, perspectives, challenges and achievements” on Tuesday June 22 at 10 a.m. CEST. The workshop will begin with an introduction on exosomes by Guillaume Van Niel; on...

Go to website >

Product

Verified

Ciloa Technology

Ciloa's unique technology makes possible to produce any type of membrane proteins (GPCR, kinase receptor, ion channel, viral protein, etc.) with their fully native conformation on exosomes outside the cell.

Go to website >

Product

Verified

Technology

For the development of new therapies or preventive strategies, it is mandatory to have membrane proteins (GPCR, ion channels, viral envelope proteins …) in the purest form but still in native conformation and integrated into a membrane.

Go to website >

View all products

Keywords

Screening ligand binding to membrane receptors

Development of native transmembrane proteins

Development of therapeutic antibodies

Development of vaccines

Development of therapeutic vectors

Pioneer of exosome based therapies and vaccines

Exosome purification and production

Biotechnology

Industries

Biotechnology

Use Cases of Ciloa SAS

Application fields

Ciloa's technology address several therapeutic areas through its three main applications : antibodies, vaccines, and therapeutic vectors. The antibodies and therapeutic vectors based on our recombinant exosomes offer new therapeutic ways in oncology, infectiology, cardiology, genetic and neurological diseases.

Visit source